中国当代医药
中國噹代醫藥
중국당대의약
China Modern Medicine
2015年
25期
36-38
,共3页
心脉隆注射液%慢性心力衰竭%电解质紊乱
心脈隆註射液%慢性心力衰竭%電解質紊亂
심맥륭주사액%만성심력쇠갈%전해질문란
Xinmailong injection%Chronic heart failure%Electrolyte disorder
目的:分析心脉隆注射液治疗慢性心力衰竭合并电解质紊乱的临床效果。方法2013年11月~2014年8月,将104例慢性心力衰竭合并电解质紊乱患者随机均分为两组,对照组给予常规治疗,研究组在常规治疗基础上给予心脉隆注射液。对比两组治疗前后的左心功能相关指标,临床疗效及安全性。结果治疗后,研究组的心率、左心室舒张末期容积(LVEDV)显著低于对照组,左心室射血分数(LVEF)显著高于对照组(P<0.05)。研究组总有效率为86.54%,显著高于对照组的69.23%(字2=7.66,P<0.05);两组患者治疗期间均未出现明显不良反应。结论心脉隆注射液治疗慢性心力衰竭合并电解质紊乱的临床效果显著,具有良好的安全性。
目的:分析心脈隆註射液治療慢性心力衰竭閤併電解質紊亂的臨床效果。方法2013年11月~2014年8月,將104例慢性心力衰竭閤併電解質紊亂患者隨機均分為兩組,對照組給予常規治療,研究組在常規治療基礎上給予心脈隆註射液。對比兩組治療前後的左心功能相關指標,臨床療效及安全性。結果治療後,研究組的心率、左心室舒張末期容積(LVEDV)顯著低于對照組,左心室射血分數(LVEF)顯著高于對照組(P<0.05)。研究組總有效率為86.54%,顯著高于對照組的69.23%(字2=7.66,P<0.05);兩組患者治療期間均未齣現明顯不良反應。結論心脈隆註射液治療慢性心力衰竭閤併電解質紊亂的臨床效果顯著,具有良好的安全性。
목적:분석심맥륭주사액치료만성심력쇠갈합병전해질문란적림상효과。방법2013년11월~2014년8월,장104례만성심력쇠갈합병전해질문란환자수궤균분위량조,대조조급여상규치료,연구조재상규치료기출상급여심맥륭주사액。대비량조치료전후적좌심공능상관지표,림상료효급안전성。결과치료후,연구조적심솔、좌심실서장말기용적(LVEDV)현저저우대조조,좌심실사혈분수(LVEF)현저고우대조조(P<0.05)。연구조총유효솔위86.54%,현저고우대조조적69.23%(자2=7.66,P<0.05);량조환자치료기간균미출현명현불량반응。결론심맥륭주사액치료만성심력쇠갈합병전해질문란적림상효과현저,구유량호적안전성。
Objective To analyze the clinical effect of Xinmailong injection in treatment of chronic heart failure com-plicated with electrolyte disorder. Methods From November 2013 to August 2014,104 cases with chronic heart failure complicated with electrolyte disorder were divided into two groups in random,control group was given conventional treatment,while study group was given Xinmailong injection on the basis of conventional treatment.The related parame-ters of the left heart function before and after treatment,clinical efficacy and safety was compared respectively between two groups. Results After treatment,the heart rate,left ventricular end-diastolic volume (LVEDV) of study group was ob-viously lower than that of control group,while left ventricular ejection fraction (LVEF) was higher than that of control group (P<0.05).The Total effective rate of study group was 86.54%,which was significantly higher than control group (69.23%) (X2=7.66,P<0.05).There were no obvious adverse reaction during treatment in both groups. Conclusion The clinical effect of Xinmailong injection in the treatment of chronic heart failure complicated with electrolyte disorder was significant and has good safe.